Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ITRM
#3825
Iterum Therapeutics plc Ordinary Share
0.2
6
+13.04%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+13.04%
Monthly Change
-21.21%
6 month change
-63.38%
Year Change
-80.60%
Previous Close
0.2
3
Open
0.2
6
Bid
Ask
Low
0.2
6
High
0.2
6
Volume
2
Markets
US Stock Market
Healthcare
ITRM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH
Iterum Therapeutics expands market access for ORLYNVAH antibiotic
Iterum Therapeutics secures major PBM agreement for antibiotic
Iterum Therapeutics receives Nasdaq notice on listing compliance
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH
Iterum’s antibiotic ORLYNVAH now available through McKesson
Iterum Therapeutics director Dunne buys $2,191 in shares
Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript
Allianz, Richemont, Swiss Re, and more set to report earnings Friday
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More - Rigetti Computing (NASDAQ:RGTI)
Iterum Therapeutics launches $20 million at-the-market share offering
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets